Protein biomarker signature for risk classification of hormone receptor positive breast cancer identified by reverse phase protein array based tumor profiling

被引：0
|
作者：
Sonntag, J. [1 ]
Bender, C. [1 ]
Aulmann, S. [2 ]
Von der Heyde, S. [3 ]
Burwinkel, B. [4 ]
Wiemann, S. [1 ]
Beissbarth, T. [3 ]
Sinn, H. P. [2 ]
Schneeweiss, A. [5 ]
Korf, U. [1 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Heidelberg Univ, Dept Pathol, Heidelberg, Germany
[3] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany
[4] Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany
[5] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1010
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [31] Reverse-phase protein array for prediction of patients unlikely to develop bone metastasis from breast cancer
    Hayashi, N.
    Manyam, G. C.
    Gonzalez-Angulo, A. M.
    Niikura, N.
    Yamauchi, H.
    Nakamura, S.
    Hortobagyi, G. N.
    Baggerly, K. A.
    Ueno, N. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S422 - S422
  • [32] Epithelial Mesenchymal Transition in Early Invasive Breast Cancer: Further Evidence Using Reverse Phase Protein Array
    Aleskandarany, M. A.
    Negm, O. H.
    Rakha, E. A.
    Ahmed, M. A. H.
    Nolan, C. C.
    Tighe, P. J.
    Green, A. R.
    Ellis, I. O.
    JOURNAL OF PATHOLOGY, 2013, 231 : 19 - 19
  • [33] Prognostic impact of phosphorylated HER2 in HER2-positive primary breast cancer using reverse-phase protein array
    Hayashi, N.
    Iwamoto, T.
    Gonzalez-Angulo, A. M.
    Ferrer-Lozano, J.
    Lluch, A.
    Niikura, N.
    Bartholomeusz, C.
    Nakamura, S.
    Hortobagyi, G. N.
    Ueno, N. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC), cell lines as platform for cancer proteomics and biomarker discovery
    Ummanni, Ramesh
    Mannsperger, Heiko A.
    Sonntag, Johanna
    Oswald, Marcus
    Sharma, Ashwini K.
    Koenig, Rainer
    Korf, Ulrike
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (05): : 950 - 959
  • [35] Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature
    Johansson, Annelie
    Yu, Nancy Y.
    Iftimi, Adina
    Tobin, Nicholas P.
    't Veer, Laura
    Nordenskjold, Bo
    Benz, Christopher C.
    Fornander, Tommy
    Perez-Tenorio, Gizeh
    Stal, Olle
    Esserman, Laura J.
    Yau, Christina
    Lindstrom, Linda S.
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (12) : 2072 - 2082
  • [36] Classification of molecular subtypes of triple-negative breast cancer using reverse phase protein arrays (RPPAs).
    Masuda, Hiroko
    Qi, Yuan
    Liu, Shuying
    Hayashi, Naoki
    Kogawa, Takahiro
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Gonzalez-Angulo, Ana M.
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
    Carvajal-Hausdorf, Daniel E.
    Mani, Nikita
    Velcheti, Vamsidhar
    Schalper, Kurt A.
    Rimm, David L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [38] Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
    Masuda, Hiroko
    Qi, Yuan
    Liu, Shuying
    Hayashi, Naoki
    Kogawa, Takahiro
    Hortobagyi, Gabriel N.
    Tripathy, Debu
    Ueno, Naoto T.
    ONCOTARGET, 2017, 8 (41) : 70481 - 70495
  • [39] The Prognostic Significance of STAT3 Expression in Invasive Breast Cancer: an Immunohistochemical and Reverse Phase Protein Array Study
    Aleskandarany, M. A.
    Negm, O. H.
    Tighe, P.
    Nolan, C.
    Green, A. R.
    Rakha, E. A.
    Ellis, I. O.
    JOURNAL OF PATHOLOGY, 2015, 237 : S32 - S32
  • [40] The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer
    Bar, Yael
    Bar, Kfir
    Itzhak, Itay
    Niselbaum, Chen Shitrit
    Dershowitz, Nachum
    Shachar, Eliya
    Weiss-Meilik, Ahuva
    Golan, Orit
    Wolf, Ido
    Menes, Tehillah
    Sonnenblick, Amir
    BREAST, 2021, 60 : 78 - 85
12345